Clinical trial Recruiting at 1 site Interventional Ages 18 to 30

How belief changes the pain we feel when we see others hurt

Official title: The Power of Belief: Expectation-driven and Placebo Modulation of Empathic Pain

Run by University of Electronic Science and Technology of China · NCT07367672 · Data updated 2026-11-12

We will test whether telling healthy adults they received oxytocin (or giving real oxytocin) changes how much pain they feel when watching others in pain during brain scans.

More Healthy Adult Participants trials

Quick facts

Study typeInterventional
Ages18 Years to 30 Years
SexAll
Enrollment120 (estimated)
SponsorUniversity of Electronic Science and Technology of China
Academic / other
Locations2 sites (Chengdu, Sichuan and 1 other locations)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedFebruary 20, 2026
Study endsMarch 30, 2026
Registry record updatedJanuary 26, 2026
Trial IDNCT07367672 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults without past or current psychiatric or neurological disorders and not taking psychotropic medications are the intended participants.

Probably not a fit

People with psychiatric or neurological histories, those on psychotropic medications, or anyone seeking direct clinical pain treatment are unlikely to benefit from participating.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Healthy adult volunteers are randomly assigned to one of three groups: no-treatment control, a placebo nasal spray described as oxytocin, or a real oxytocin nasal spray. While undergoing functional MRI, participants watch naturalistic videos of people in painful situations and rate the pain they perceive. Behavioral responses will be transformed into analgesia-weighted scores, and neural data will include voxel-wise activity, multivariate predictive patterns, and directed functional connectivity analyses. Group comparisons will test how cognitive belief and oxytocin change subjective empathic pain and the brain network interactions that support it.

Why it matters

Potential benefit: If successful, this work could show ways to reduce empathic distress by using expectations or neuromodulators, informing future approaches to manage excessive empathic pain.

How similar studies have gone: Previous placebo and oxytocin studies in pain and social processing have produced promising but mixed results, so similar approaches have shown some success but are not yet conclusive.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* (1) Healthy subjects without any past or present psychiatric or neurological disorders; (2) Healthy subjects without any current psychotherapeutic medication.

Exclusion Criteria:

* (1) Participant with any past or present psychiatric or neurological disorders; (2)Participant with any current psychotherapeutic medication.

Where it's running

  • Weihua Zhao
    Chengdu, Sichuan, China
    Recruiting
  • University of Electronic Science and Technology of China
    Chengdu, China
    Enrolling by invitation

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.